Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Janus Kinase‐1 and Janus Kinase‐2 Inhibitors for Treating Myelofibrosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/images/ios-appstore-badge.png. Accessed 05 May 2024.
Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/images/ios-appstore-badge.png. Accessed May 5, 2024.
Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/images/ios-appstore-badge.png
Janus Kinase‐1 and Janus Kinase‐2 Inhibitors for Treating Myelofibrosis [Internet]. In: Cochrane Abstracts. [cited 2024 May 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis
ID - 437055
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -